Table 2. Summary of included studies.
First author, year | Location | Study design1 | Sampling strategy2 | Target population | HIV+ adolescents/ youth |
---|---|---|---|---|---|
Ankunda 2011 [77]; Ankunda 2016 [50] | Uganda | CS | FP; TR | 15–24 year old HIV+ | n = 425 (2011) n = 335 (2016) |
Bakeera-Kitaka 2008 [58] | Uganda | CS | FP; PS | 15–24 year old HIV+ | n = 75 |
Banura 2008 [57] | Uganda | CS | FP; CS | 12–24 year old HIV+ and HIV- | n = 82 |
Baryamutuma 2010 [59] | Uganda | CS | FP; CS | 13–19 year old HIV+ | n = 386 |
Beyeza-Kasheysa 2011 [60] | Uganda | CS (PCS) | FP; CS | 15–24 year old HIV+ & HIV- | n = 276 (2009) n = 206 (2011) |
Birungi 2009 [51]; Birungi 2009 [74]; Obare 2010 [118] | Uganda | CS | FP-CP; CS | 15–19 year old HIV+ and status unknown) | n = 732 |
Birungi 2011 [61] | Kenya | CS | FP; PS | 15–19 year old HIV+ females | n = 757 |
Cataldo 2012 [28] | Malawi, Mozambique, Zambia, Zimbabwe | CS | NR; CS | 10–19 year old HIV+ | n = 1,703 |
Gavin 2006 [68] | Zimbabwe | CS | CRS; TR | 15–19 year old | n = 192 |
Gray 1998 [69] | Uganda | CS (RCT) | CRS; TR | 15–49 year old females | n = 361 |
Heffron 2010 [70] | Eastern Africa: Kenya, Rwanda, Tanzania, Uganda Southern Africa: Botswana, South Africa, Zambia |
CS | CRS; TR | 18–45 year old females | n = 523 |
Hendriksen 2007 [71]; Steffenson 2011 [83] | South Africa | CS | CRS; TR | 15–24 year old | n = 1,235 (2007); n = 1,091 (2011) |
Hoffman 2008 [62] | Malawi | CS (PCS) | FP; PS | 18+ year old HIV+ females | n = 90 |
Holub 2010 [63] | Democratic Republic of Congo | CS | FP; PS | 14–24 year old HIV+ | n = 103 |
Kaggwa 2012 [125] | Uganda | CS | FP; NR | 16–24 year old HIV+ | n = 453 |
Katusiime 2012 [56] | Uganda | CS | FP; PS | 15–24 year old HIV+ | n = 148 |
Kembo 2012 [72] | Zimbabwe | CS | CRS; NR | 15–24 year old HIV+ and HIV- | n = 477 |
Lightfoot 2007 [41] | Uganda | RCT | CNR; CS | 14–21 year old HIV+ | n = 100 |
Malaju 2013 [67] | Ethiopia | CS | FP; NR | 15–24 year old HIV+ and HIV- | n = 104 |
Mbalinda 2015 [52]; Mbalinda 2015 [114] | Uganda | CS | FP-FRS; PS | 10–19 year old HIV+ | n = 624 |
Mhalu 2013 [76] | Tanzania | CS | FRS; TR | 15–24 year old HIV+ | n = 232 |
Morris 2012 [31] | Cameroon | CS | FRS-CP; TR | 12–26 year old HIV+, HIV-, status unknown | n = 114 |
Muyindike 2012 [65] | Uganda | CS | FP; NR | 18–49 year old women (n = 826) | n = 211 |
Nhamo 2013 [87]; Nhamo 2014 [78] | Zimbabwe | RCT | NR; NR | 16–19 year old HIV+ | n = 710 |
Nöstlinger 2015 [55] | Uganda | CS (PCS) | FC-CC; PS | 13–17 year old HIV+ | N = 532 |
Obare 2010 [53] | Kenya | CS | FP; PS | 15–19 year old HIV+ | n = 606 |
Pascoe 2015 [73] | Zimbabwe | CS | CRS; TR | 18–22 year old HIV+ and HIV- | n = 199 |
Santelli 2013 [32] | Uganda | CS (PCS) | CRS; TR | 15–24 year old HIV+ and HIV- | n = 204 |
Senyonyi 2012 [42] | Uganda | RCT | FP; CS | 12–18 year old HIV+ | n = 115 |
Shisana 2014 [29] | South African | CS | CRS; TR | All ages HIV+ and HIV- | n = 443 |
Snyder 2014 [40] | South Africa | PPT | FC-CC; CS | 16–24 year old HIV+ | n = 65 |
Test 2012 [75] | Rwanda | CS | FC-CC; CS | 16–24 year old HIV+ | n = 107 |
Toska 2015 [54] | South Africa | CS | FRS-CP; TR | 10–19 year old HIV+ | n = 858 |
Viegas 2015 [47] | Mozambique | CS | FC; PS | 18–24 year old HIV+ and HIV- | n = 85 |
Wanyenze 2011 [66] | Uganda | CS | FP; CS | 15–49 year old HIV+ | n = 159 |
1 CS cross-sectional study, PCS prospective cohort survey, PPT pre and post-test; RCT randomised controlled trial.
2 Sampling strategy documented at two levels: (1) cluster: facility random and/ or stratified (FRS); facility purposeful (FP), community random and/or stratified (CRS), community purposeful (CP), mixed–see symbols (2) individual: total/ random (TR), purposeful (PS), convenience (CS); NR–not reported.